Bone Biologics (BBLG) Return on Equity (2016 - 2017)
Bone Biologics has reported Return on Equity over the past 2 years, most recently at 0.01% for Q4 2017.
- Quarterly Return on Equity fell 3.0% to 0.01% in Q4 2017 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2017, down 3.0% year-over-year, with the annual reading at 0.01% for FY2017, 3.0% down from the prior year.
- Return on Equity was 0.01% for Q4 2017 at Bone Biologics, down from 0.01% in the prior quarter.
- Over five years, Return on Equity peaked at 0.03% in Q3 2016 and troughed at 0.01% in Q4 2017.